Literature DB >> 34252517

The rate of superior oblique surgery in children and adolescents with Brown syndrome according to claims data.

Hwan Heo1, Scott R Lambert2.   

Abstract

PURPOSE: To determine the rate of superior oblique surgery and how often it is combined with surgery on other extraocular muscles or associated with subsequent strabismus surgeries in children and adolescents with Brown syndrome.
METHODS: This was a population-based retrospective cohort study using the Optum deidentified Clinformatics Data Mart Database (2004-2018) for patients ≤18 years of age diagnosed with Brown syndrome who underwent superior oblique surgery as their first strabismus surgery and had at least 6 months of continuous enrollment. We assessed sex, age, and the number of included patients by year and by age. Combined and subsequent strabismus surgeries were also investigated.
RESULTS: Of 1,007 patients diagnosed with Brown syndrome, 115 (11.4%) underwent superior oblique surgery. The rate of superior oblique surgery was relatively constant between 2004 to 2018. The superior oblique surgery rate was highest in children ≤2 years of age with a decreasing rate as age increased. In 45 of 115 patients (39.1%), other extraocular muscles were operated on in addition to the superior oblique muscle. Of 88 patients who underwent superior oblique surgery without concurrent vertical muscle surgery as the first operation, 11 patients (12.5%) subsequently underwent an additional vertical muscle surgery because of newly developed or worsening vertical misalignment.
CONCLUSIONS: In this study cohort, superior oblique surgery was performed on 11.4% of children and adolescents with Brown syndrome. The number of patients with Brown syndrome and the rate of superior oblique surgery decreased as age increased to age 10 years.
Copyright © 2021 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34252517      PMCID: PMC8449810          DOI: 10.1016/j.jaapos.2021.03.009

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.325


  23 in total

1.  Spontaneous regression of pseudoparalysis of the inferior oblique muscle.

Authors:  F D COSTENBADER; D G ALBERT
Journal:  AMA Arch Ophthalmol       Date:  1958-04

2.  Superior oblique tendon thinning for Brown syndrome.

Authors:  Alicia Galán; Noemí Roselló
Journal:  J AAPOS       Date:  2021-02-20       Impact factor: 1.220

3.  An adjustable superior oblique tendon spacer with the use of nonabsorbable suture.

Authors:  D W Suh; D L Guyton; D G Hunter
Journal:  J AAPOS       Date:  2001-06       Impact factor: 1.220

4.  Spontaneous cure of congenital Brown's syndrome.

Authors:  C R Leone; R T Leone
Journal:  Am J Ophthalmol       Date:  1986-10-15       Impact factor: 5.258

5.  Simultaneous superior oblique tenotomy and inferior oblique recession in Brown's syndrome.

Authors:  M M Parks; H S Eustis
Journal:  Ophthalmology       Date:  1987-08       Impact factor: 12.079

6.  Horizontal Deviations in Congenital Brown Syndrome.

Authors:  Gad Dotan; Maya Eiger-Moscovich; Moshe Snir; Miriam Ehrenberg; Ronit Friling
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2017-12-19       Impact factor: 1.402

7.  Spontaneous resolution in patients with congenital Brown syndrome.

Authors:  Emma Dawson; John Barry; John Lee
Journal:  J AAPOS       Date:  2008-12-12       Impact factor: 1.220

8.  Super oblique tendon elongation with fascia lata.

Authors:  Mohammad Reza Talebnejad; Masoomeh Eghtedari; Naser Owji; Alireza Alavi
Journal:  J AAPOS       Date:  2008-10       Impact factor: 1.220

Review 9.  Brown's syndrome.

Authors:  M E Wilson; H S Eustis; M M Parks
Journal:  Surv Ophthalmol       Date:  1989 Nov-Dec       Impact factor: 6.048

10.  Late results of superior oblique muscle tenotomy in true Brown's syndrome.

Authors:  J S Crawford; R B Orton; L Labow-Daily
Journal:  Am J Ophthalmol       Date:  1980-06       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.